You Searched For "anti Covid pill Molnupiravir" and got 20 results
Sort By:
2 mins read
Sun Pharma gets emergency use authorization to manufacture Merck's anti-Covid pill Molnupiravir
Amid the ongoing resurgence of new Covid-19 cases in India, an expert panel of the Central Dru…
4 mins read
India allows emergency use of Merck's new drug Molnupiravir for treatment of mild-to-moderate COVID-19 cases
An expert panel of the country's central drug authority has recommended granting emergency use auth…
PTI
4 mins read
Sun Pharma, Dr Reddy’s Lab, Divi’s Lab and other pharma stocks rally on regulator’s nod to make anti-COVID pill
Pharmaceutical company stocks were the top gainers in a weak market on December 29 as the segment c…
2 mins read
Merck jumps 10% as the drugmaker says its antiviral pill cuts the risk of hospitalizations and deaths in COVID patients
Merck already has a deal to supply 1.7 million courses of antiviral pill molnupiravir to the US gov…
Carla Mozée
1 min read
Retail investors are dumping shares of COVID-19 vaccine makers and piling into antiviral pill maker Merck, data shows
Merck shares have jumped since the drug maker said molnupiravir cuts the risk of COVID hospitalizat…
Carla Mozée
2 mins read
ICMR experts reject inclusion of Molnupiravir in COVID-19 treatment guidelines for fourth time citing safety concerns
Responding to a question over Molnupiravir's inclusion in the treatment guidelines amid doctors …
PTI
2 mins read
Russian anti-Covid pill Avifavir reportedly effective against Delta and Omicron variants
Avifavir affects the highly conservative and mutation-resistant replication systems of RNA virus…
6 mins read
Dogs owners are feeding their dogs cheap pills to help them live longer if it works, it could be an anti-aging fix for people too
Dogs across the US are taking the drug rapamycin to see if it helps them live longer and stay healt…
Hilary Brueck
3 mins read
A cheap drug used for anti-aging and weight-loss may also prevent long COVID, study finds
Metformin is a cheap, easy-to-access drug that used for diabetes, longevity, and losing weight. It …
Leah Rosenbaum
1 min read
Merck requests FDA authorization for its anti-COVID-19 pill, the next step towards rolling it out
The pill "significantly reduced the risk of hospitalization or death," according to the developers …
Marianne Guenot
1 min read
Top Stories this PM: Merck requests authorization for anti-COVID pill; Facebook Oversight Board to meet with whistleblower
If authorized, the drug, called molnupiravir, would become the first oral antiviral treatment for C…
INSIDER
4 mins read
The first-ever COVID-19 pill may be just weeks away. A handful of other pills, inhalers, and nasal sprays also show promise.
Easy-to-take coronavirus treatments could complement vaccines. These are the most promising ones to…
Aria Bendix,Andrew Dunn
2 mins read
What's ahead for COVID-19 treatments after Pfizer says its antiviral pill works
These are Insider's biggest healthcare stories for the week ending November 5.
Leah Rosenbaum
2 mins read
Americans at risk of severe COVID-19 to receive free Pfizer antiviral pills after a positive test
"If you get COVID-19, the Pfizer pill reduces your chances of ending up in the hospital by 90%," Pr…
Dr. Catherine Schuster-Bruce
3 mins read
I run one of the only 2 pharmacies that provides mail-order abortion pills. It's been a scary and wild time.
Jessica Nouhavandi, a cofounder of Honeybee Health, said orders rose by 50% the week after Roe was …
Urooba Jamal
4 mins read
The FDA has authorized pills to treat COVID-19, replenishing the tool kit of treatments against Omicron
The FDA on Thursday authorized Merck's antiviral pill, one day after authorizing Pfizer's pill.
Andrew Dunn,Allison DeAngelis
3 mins read
The FDA could authorize the first COVID-19 pill in December - here's who may be eligible
Next month, the FDA will meet to discuss Merck's antiviral pill for adults with mild to moderate CO…
Aria Bendix
2 mins read
Dow spikes 482 points after Merck's COVID-19 pill boosts recovery optimism
US stocks still closed the week lower on Friday, but well off the lows sparked by higher interest r…
Matthew Fox
1 min read
Pfizer soars 11% on strong results from COVID-19 pill study, while Moderna and Merck tumble
Pfizer plans to seek the Food and Drug Administration's OK this month for the pill, with doses pote…
Phil Rosen
1 min read
Moderna and BioNTech plummet more than 15% following news of Merck's COVID-19 antiviral pill
The antiviral drug could put a dent into the uptake of COVID-19 vaccines, as countries still strugg…